Nationwide Institute on Drug Abuse Units Normal Dose of THC for Hashish Analysis

The results of In vivo research on medical cannabis continues to mature into workable data. So far, the studies have lacked a standard dose.

On May 7, the National Institute on Drug Abuse (NIDA) announced that it had established a standard dose of tetrahydrocannabinol (THC) for medical cannabis studies. The new standard is five milligrams of THC.

“Inconsistencies in measuring and reporting THC exposure were a major limitation in cannabis use studies, making it difficult to compare results between studies,” said NIDA Note for information says. “Standardized measurement of THC in cannabis products is needed to advance research by allowing better comparability between studies for both adverse and potential medicinal uses.”

NIDA hit the five milligram cap after receiving input from stakeholders, consulting cannabis experts, and gathering information from the public. You are aware that even with a THC cap, many people experience this dosage differently depending on a number of factors including how Cannabis is consumed.

Still, a THC dose of five milligrams may be limiting for some studies. For example, individuals struggling with chronic pain may not get the therapeutic benefits of cannabis at just 5 mg of THC. Indeed, a study reported that THC levels should be up to 40 mg when a patient becomes unresponsive at lower doses.

Not to mention, in places where recreational and medical cannabis is legalized, many of the products on the market contain more than 5 mg of THC per serving. So expect many who don’t even wait for cannabis studies to go well beyond the NIDA limit.

It’s a relief to see large organizations like NIDA start to worry about the parameters of cannabis research. In addition, setting a standard for the THC dose offers the advantage of a study comparison. However, it cannot be overlooked that a maximum dosage can limit the potential supply of cannabis.

Comments are closed.